银河糖:一种多功能载体,揭示了药物输送,诊断和治疗术的潜力
Chiara Battisegola1, Chiara Billi1, Maria Cristina Molaro1
1Department of Pharmacy, "Federico II" University of Naples, 80131 Naples, Italy.
Pharmaceuticals (Basel, Switzerland)
|March 28, 2024
概括
D-银糖作为一种多功能支架,用于向药物输送和诊断. 本综述更新了其在前药物设计中的使用,增强细胞吸收和肝功能评估.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- D-银糖是一种具有独特性质的天然单糖.
- 它与特定的细胞受体相互作用,使得有针对性的应用成为可能.
- 银河糖在药物输送,诊断和治疗术方面有潜力.
研究的目的:
- 提供关于D-银河糖作为载体的最新审查.
- 突出其在前药物设计,诊断和治疗学中的应用.
- 讨论基于银河糖的药物的合成策略.
主要方法:
- 对D-银糖应用的文献综述.
- 分析了银河糖作为向连接体的作用.
- 检查使用银河糖的诊断测试.
- 复习了治疗药物设计的方法.
主要成果:
- 当与药物或药物载体结合时,D-银糖会增强细胞吸收药物.
- 它针对特定的细胞,如肝细胞,巨细胞和癌细胞.
- 基于银河糖的测试,如银河糖消除能力,评估肝功能.
- 结合药物输送和诊断的精神药剂是可行的.
结论:
- D-银河糖是高级生物医学应用的高度通用的载体.
- 它能够准特定的细胞并帮助诊断是至关重要的.
- 对合成策略的进一步研究将扩大其实用性.
相关概念视频
Secondary Active Transport
7.0K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme "pump" embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
7.0K
Glucose Transporters
22.7K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.7K
Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K


